We study how enhancers, the regulatory switches that control gene expression, shape the developing human brain and how disruption of their activity contributes to neurodevelopmental and neurodegenerative disease. By integrating chromatin biology, CRISPR-based functional genomics, and human iPSC models, we aim to uncover the molecular basis of brain disorders and improve the interpretation of non-coding genetic variation in clinical genomics.